CATHYLEEN WATKINS FILIPPI
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner VERO BEACH, FL NPI 1598313256
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FL Axonics Modulation Technologies, Inc. All categories
General Payments — all program years on this page
$11,047.20
- Category: General Payments
- Program years: PY2021–2024
- Record count: 330
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,233.21 across 38 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,202.21 | 37 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Axonics Modulation Technologies, Inc. | $357.91 | 8 |
| COLOPLAST CORP | $148.38 | 1 |
| PROCEPT BioRobotics Corporation | $136.92 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $75.65 | 3 |
| Incyte Corporation | $50.41 | 2 |
| PFIZER INC. | $40.02 | 2 |
| Pharmacosmos Therapeutics Inc. | $38.14 | 2 |
| Janssen Biotech, Inc. | $35.14 | 2 |
| Laborie Medical Technologies Corp. | $31.09 | 2 |
| Sumitomo Pharma America, Inc. | $31.00 | 1 |
| AVEO Pharmaceuticals, Inc. | $26.77 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $26.20 | 1 |
| Acerta Pharma LLC | $24.03 | 1 |
| Ferring Pharmaceuticals Inc. | $23.39 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.38 | 1 |
| TerSera Therapeutics LLC | $22.22 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $20.74 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.65 | 1 |
| Merck Sharp & Dohme Corporation | $19.11 | 1 |
| Agios Pharmaceuticals, Inc. | $18.85 | 1 |
| TAIHO ONCOLOGY, INC. | $17.16 | 1 |
| Regeneron Healthcare Solutions, Inc. | $16.16 | 1 |
| ACCORD HEALTHCARE, INC. | $15.80 | 1 |
| Celgene Corporation | $15.09 | 1 |
By program year
Records — PY2024 (38)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.